Company Filing History:
2 out of 810 
1 out of 2 Years Active: 2012-2013
Title: Maya Maor: Innovator in Neuroprotective Therapies
Introduction
Maya Maor is a prominent inventor based in Petach-Tikva, Israel. She has made significant contributions to the field of neuroprotective therapies, holding 2 patents that focus on innovative treatments for neuronal disorders. Her work is characterized by a deep understanding of neurobiology and the development of novel therapeutic agents.
Latest Patents
Maya Maor's latest patents include groundbreaking inventions related to therapeutics based on tau/microtubule dynamics. This invention is based on the discovery of a novel neuroprotective peptide. It highlights the NAP peptide's ability to enhance the association of tau and the brain-specific beta tubulin subunit. Furthermore, NAP modifies microtubule assembly and dynamics by affecting the tyrosination of microtubule proteins. The invention provides compositions and methods for the treatment and prevention of neuronal disorders, including NAP-binding and tau-binding agents, tau peptide mimetics, and NAP-like tau peptide mimetics. Another significant patent focuses on neuroprotection using NAP-like and SAL-like peptide mimetics. This invention relates to polypeptides or small molecules derived from these mimetics and their use in treating neuronal dysfunction, neurodegenerative disorders, cognitive deficits, neuropsychiatric disorders, and autoimmune diseases.
Career Highlights
Maya Maor has worked with esteemed institutions, including Tel Aviv University and Allon Therapeutics, Inc. Her career is marked by a commitment to advancing the understanding and treatment of neurological conditions.
Collaborations
Maya has collaborated with notable colleagues, including Illana Gozes and Alistair Stewart. These partnerships have further enriched her research and contributed to her innovative work in neuroprotection.
Conclusion
Maya Maor stands out as a leading inventor in the field of neuroprotective therapies. Her patents reflect her dedication to improving treatments for neuronal disorders and her innovative approach to neurobiology.